November 13, 2019 – November 14, 2019
Karen DeBalsi, PhD, Senior Study Director, Discovery and Translational Sciences, Metabolon, Inc.
Small Molecules at the Intersection of Health and the Microbiota
November 13, 2019 at 6:00 PM
- Overview of the foundational value of metabolomics in the study of disease and drug development
- Essential components of Gold Standard metabolomics solutions
- Key strategies to ensure actionable therapeutic application
- Reviews of proven microbiome metabolomic case studies
If you’d like to attend please register your interest by emailing firstname.lastname@example.org.